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ABSTRACT DNA fragments from Pseudomonas aeruginosa
carrying the PaeR7 restriction/modification genes have been
cloned in the plasmid vector pBR322 and propagated in Esche-
richia coli A subclone (pPAORM3.8) has been constructed that
contains the complete restriction/modification system on a 3.8-
kilobase DNA fragment. Digestion of the pPAORM3.8 plasmid
with nuclease BAL-31 has yielded two types of clones. One type
contains an active methylase gene but no active endonuclease
gene; such clones will modify the DNA but not restrict the growth
of incoming phage in vivo. The second type contains an active en-
donuclease gene but no active methylase gene, as judged both by
in vivo tests and by the activity ofthe cell extracts in vitro. Although
extracts of cells containing these plasmids display restriction en-
donuclease activity, these bacteria are unable to restrict the
growth ofincoming phage. Furthermore, chromosomal and phage
DNA isolated from these host cells are not protected against cleav-
age by PaeR7 in vitro. The properties of PaeR7 endonuclease and
methylase enzymes have also been examined. The PaeR7 restric-
tion endonuclease recognizes and cleaves the sequence C J T-C-
G-A-G, as does Xho I. However, there exists a canonical Xho I site
at 26.5% on the adenovirus 2 genome which is totally refractory
to PaeR7 cleavage but is cut byXho I. Under conditions of low salt,
high glycerol, and high enzyme concentrations, a "PaeR7*" activ-
ity is found that is similar to that observed for EcoRI. Finally, evi-
dence is presented that the PaeR7 methylase modifies the adenine
residue within the recognition sequence.
In many bacteria, restriction/modification systems produce
strain-specific enzymes that allow host cells to recognize and
destroy foreign DNA. This is accomplished by a restriction en-
donuclease that makes double-strand scissions at a limited num-
ber of specific sites on the DNA. In addition to restriction ac-
tivity, such bacterial strains possess a corresponding DNA
methylase that modifies specific adenine or cytosine residues
within the sequence recognized by the nuclease. The methyl-
ation protects the cell's DNA against the action of its own re-
striction enzymes (1-4).
The genes for restriction/modification systems may be en-
coded on chromosomal, phage, or plasmid DNAs (1). The PaeR7
system belongs to the third category. It is encoded by a 42-kilo-
base (kb) plasmid, pMG7, carried in Pseudomonas aeruginosa
(5). We were able to use the system's plasmid location to facil-
itate its cloning.
We have used molecular cloning to transfer the PaeR7 re-
striction/modification system into Escherichia coli. Further-
more, we have been able to divide the system and generate two
types of subclones: those that express only the methylase gene,
and those that express only the endonuclease gene. The viability
of the latter class of clones is surprising because the chromo-
somal DNA from these clones is susceptible to PaeR7 cleavage.
The existence of endonuclease+ methylase- cells suggests that
there are unknown control elements acting in vivo.
MATERIALS AND METHODS
Bacterial Strains and Phage Stocks. The E. coli MM294
(recA+, rK mK+) (6) was obtained from D. Levy. P. aeruginosa
strain PA0303 (pMG7) was provided by G. Jacoby. Phage 480
was provided by D. Friedman.
DNA Preparations. Plasmid DNA used in the cloning and
mapping experiments was isolated by the cleared lysate method
(7) followed by banding in CsCl/ethidium bromide gradients.
"Minipreparations" ofplasmid DNA from clones were obtained
by a modified version of the procedure of Birnboim and Dolly
(8). Chromosomal DNA preparations were made by the method
of Marmur (9). Adenovirus type 2 (Ad2) DNA was prepared by
the method of Pettersson and Sambrook (10). pBR322 deriva-
tives (pX164 and pX2281) containing Xho I linkers at positions
164 and 2,281, respectively, were supplied by T. J. Kwoh.
Restriction Enzymes and 5' Mono- and Dinucleotide Anal-
ysis. The restriction endonucleases Sal I, HincII, BstNI, EcoRI,
BamHI, HindIII, Pst I, Nru I, Xho I, and Xma I were obtained
from New England Biolabs. Digestions using these enzymes
were performed under conditions recommended by the man-
ufacturer. Kpn I, Rsa I, Bcl I, and PaeR7 were prepared by P.
Myers in this laboratory. Kpn I, Rsa I, and Bcl I digestions were
performed in buffer containing 6 mM Tris, pH 7.9/6 mM
SHCH2CH2OH/6 mM MgCl2. PaeR7 digestions were done in
150 mM NaCl/6 mM Tris, pH 7.9/6 mM MgCl2/6 mM
SHCH2CH20H containing 100 ,g of bovine serum albumin
per ml (final volume, 50 ,ul) at 37°C for 2 hr. PaeR7* digestions
were performed in 6 mM Tris, pH 7.9/6 mM MgCl2/6 mM
SHCH2CH2OH/20% (vol/vol) glycerol, with an excess of
PaeR7 enzyme; incubation was for 12 hr at 37°C.
Calf alkaline phosphatase and T4 polynucleotide kinase
(Boehringer Mannheim) were used to label the 5' ends ofDNA
fragments generated by Xho I and PaeR7 as described by Cha-
conas and van de Sande (11). The 5' mononucleotides and dinu-
cleotides from 5' 32P-end-labeled Xho I and PaeR7 fragments
were determined by using snake venom phosphodiesterase and
exonuclease I (Sigma) followed by high-voltage electrophoresis
(12).
Construction of Clones. pBR322 plasmids carrying DNA
fragments from pMG7 were constructed by digesting pMG7
DNA (1 ,ug) with BamHI and ligating the resulting fragments
to phosphatase-treated BamHI-cleaved pBR322 (0.1 ,ug) by
using T4 DNA ligase. E. coli MM294 cells (=5 X 109) were
transformed by the CaCl2/heat-shock method of Cohen et al.
(13). Transformants were selected on LB agar plates containing
100 ,ug of ampicillin per ml. A total of 27 transformants were
Abbreviations: kb, kilobase(s); Ad2, adenovirus type 2.
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obtained; 9 contained inserts from pMG7.
pPAORM3.8 was prepared by digesting 2 pug of pPAORM38b
with Nru I. The resulting fragments were recircularized with
T4 ligase and used to transform MM294.
Further deletions were made in this subelone by treatment
of the plasmid DNA with BAL-31. Ten micrograms of
pPAORM3.8 DNA (Fig. 1) was linearized with either BamHI
or Nru I, and the DNA was treated with 2 units of BAL-31 nu-
clease (Bethesda Research Laboratories) under conditions rec-
ommended by the manufacturer. Aliquots (10-pl) were re-
moved at intervals of 30 sec and 1, 2, 3, and 5 min. To each
aliquot was added 20 p1L of 100 mM EDTA to stop the reaction,
and the samples were phenol treated and precipitated. The
ends of the BAL-31-treated DNA fragments (2 pug) were re-
paired by using 1.4 units of the Klenow subfragment of DNA
polymerase I (New England Biolabs) at 12'C for 45 min. In the
case of pPAORM3.8 DNA opened at the BamHI site, the re-
paired blunt-ended fragments were religated with T4 ligase by
incubation at 40C for 24 hr. With plasmids opened at the Nru
I site, the repaired blunt-ended fragments were ligated to Sal
I linkers (Collaborative Research, Waltham, MA; ratio of ends
to linker, 1:20) and cleaved with Sal I, and the complementary
ends of the Sal I site rejoined by T4 ligase to recircularize the
plasmid.
Assays of Restriction and Modification Enzymes. (a) In vitro
assays. Extracts were prepared from 5.0 ml of transformed or
control cells to detect the presence of the restriction or modi-
fication enzymes. After low-speed centrifugation, cells were
resuspended in 500 u1l of 10 mM Tris, pH 7.6/10 mM
SHCH2CH2OH/10 mM EDTA containing 0.5 mg of lysozyme
and subjected to a cycle offreezing and thawing followed by 15
sec of sonication to disrupt the cell wall. MgCl2 was added to
a final concentration of 10mM and the cell debris and DNA was
pelleted by centrifugation. PaeR7 endonuclease activity was
tested by digesting 2 ,ug ofAd2 with 4 ,ul of extract at 37C for
10 min. The digestion products were analyzed by electropho-
resis (14). PaeR7 methylase activity was tested by incubating
(37°C; 30 min) 1 ,ug of Ad2 DNA with 10 ,ul of cell extract in
a 50-plI reaction mixture containing 50 mM Tris (pH 7.5), 10
mM EDTA, 10 mM SHCH2CH2OH, and 0.1 mM S-adenosyl-
methionine. As a control the DNA was treated similarly but in
the absence of S-adenosylmethionine. The Ad2 DNA was pu-
rified by phenol extraction and ethanol precipitation, chal-
lenged with PaeR7 or Xho I under conditions described above,
and analyzed on a 1% agarose gel.
(b) In vivo assays. Transformants were screened for the ability
to restrict and modify 480 phage in vivo. To test for restriction,
aliquots (0.1 ml) of transformant cultures were spot-tested with
a dilution series from a high-titer phage stock, as described by
Mann et aL (15). To test for phage modification, phage were
picked from plaques on the transformed host and resuspended
in 1 ml of 10 mM Tris, pH 7.4/5 mM MgCl2/0.2 M NaCl/
0.1% gelatin equilibrated with chloroform; the phage were se-
rially diluted and spotted on both nonrestricting (MM294) and
restricting [MM294 (pPAORM38b)] host cells.
Nomenclature. A standard method for naming plasmids con-
taining restriction or modification genes has been adopted.
Plasmids are described by: "p" for plasmid; the three letter ab-
breviation ofthe restriction/modification system (PAO); "R" for
the restriction gene, "M" for the methylase gene, or "RM" for
both genes;,ancla numeral for the size of the insert in kb. For
example, a plasmid carrying both the restriction and modifi-
cation genes from P. aeruginosa on a 3.8-kb insert is named
"pPAORM3.8." Multiple plasmids containing the same com-
plement of restriction or modification genes or both on the
same-size insert fragment are further denoted by a letter after
the size designation (see below).
RESULTS
Properties ofPaeR7 Clones. The initial transfer ofthe PaeR7
restriction/modification system into E. coli was accomplished
by ligating BamHI fragments of pMG7 to pBR322 (Fig. 1). All
clones generated were then tested for restriction and modifi-
cation both in vivo and in vitro. Three types of plasmids were
of interest: pPAORM42, containing the complete pMG7 (42-kb)
inserted into pBR322; pPAORM38a, containing a 38-kb frag-
ment ofpMG7 ligated to pBR322; and pPAORM38b, containing
the same 38-kb fragment but ligated to pBR322 in the opposite
orientation. All three types of clones produced PaeR7 endo-
nuclease and methylase as shown by in vitro assays (Fig. 2). In
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FIG. 1. Restriction enzyme maps ofpMG7 andpBR322 clones containingthePaeR7 endonuclease or the methylase gene. ThePaeR7 restriction/
modification system is within the 42-kb pMG7 P. aeruginosa plasmid. Both the endonuclease and methylase genes are present in pPAORM3.8.
BAL-31 digestion from theBamHI site inpPAORM3.8 produced a clone (pPAOR1.9) which expressed only the endonuclease gene. BAL-31 digestion
from the Nru I site in pPAORM3.8 yielded a clone (pPAOM2.7) which expressed only the methylase gene. The Sal I/HincH linker present in
pPAOM2.7 is represented as a clear area. The total size of each plasmid is listed in parentheses below each construction.
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FIG. 2. Graphic summary of the pBR322 clones containing segments of pMG7. Each clone containing an insert from pMG7 was tested by in
vitro and in vivo assays for the presence of the PaeR7 restriction/modification system. Although pPAORM38a and pPAORM38b plasmids have
the same insert in opposite orientations (11), pPAORM38a will not plate phage but pPAORM38b will. + +, increased levels of methylase and re-
striction endonuclease activity.
the in vivo assays, pPAORM42 and pPAORM38b restricted the
growth and modified the DNA of 480 phage: unmodified 480
had an efficiency of plating of i0' on hosts containing these
plasmids compared to control MM294 host cells; modified
phage had an efficiency of 1.0. Cells containing the pPAORM38a
plasmid, however, were unable to produce plaques of either
080 or A phage. This was unexpected because pPAORM38a and
pPAORM38b contain the same pMG7 fragment.
Subelones derived from pPAORM38a and pPAORM38b
were prepared by restriction enzyme cleavage and religation
to generate smaller plasmids containing the restriction/mod-
ification system. The smallest ofthese constructs, pPAORM3.8,
contained a 3.8-kb fragment from pMG7. It both restricted and
modified the DNA of 480 phage as well as produced large quan-
tities of PaeR7 endonuclease and methylase (Fig. 2).
To reduce further the size of the insert and to determine the
order ofthe restriction/modification genes within this segment
of DNA, the pPAORM3.8 plasmid was opened at either the
BamHI or Nru I site, treated with BAL-31 nuclease, and then
religated. The smallest ofthe clones generated by BAL-31 treat-
ment at the Nru I site contained a 2.7-kb fragment from pMG7
(Fig. 1). This plasmid, designated pPAOM2.7, made active
methylase and modified the DNA of 480 phage; however, it no
longer restricted incoming phage, nor did it contain endonu-
clease as judged by an in vitro assay (Fig. 2). A more unusual
set of clones were generated by BAL-31 treatment of BamHI-
cut pPAORM3.8. These clones made PaeR7 endonuclease but
not methylase; they neither restricted nor modified the DNA
of 480 phage (Fig. 2). The smallest ofthese constructs contained
a 1.9-kb insert and is designated pPAOR1.9 (Fig. 1). A com-
posite ofthe two sets ofBAL-31 clones indicated the order (from
the BamHI site to the Nru I site) of the genes to be first the
methylase and then the endonuclease gene.
The endonuclease+ modification- pPAORl.9 clone was char-
acterized in several ways. It was determined whether chro-
mosomal DNA from the pPAOR1.9-containing clone was pro-
tected against cleavage by PaeR7 (or its isoschizomer, Xho I).
Chromosomal DNA isolated from the pPAOR1.9 clone was sen-
sitive to cleavage by PaeR7 or Xho I (not shown) as was DNA
from 080 phage grown in these cells (Fig. 3). However, chro-
mosomal and phage DNAs isolated from clones with the R'M'
phenotype all were modified against PaeR7 and Xho I cleavage
(Fig. 3).
Despite the fact that chromosomal DNA from the pPAOR1.9
clone was unmodified, the clone was stable. There were no
observable changes in plasmid structure (with respect to its re-
striction map) after three rounds of plasmid isolation and re-
transformation. In addition, secondary and tertiary transfor-
mants still produced restriction endonuclease at the same level.
Properties of the PaeR7 Endonuclease. It had previously
been noted that PaeR7 and Xho I have a common recognition
sequence, C-T-C-G-A-G (ref. 16; P. Myers, personal commu-
nication). However, the cleavage site of PaeR7 had not been
determined. Therefore, Ad2 DNA was cleaved with either
PaeR7 or Xho I; the fragments generated were labeled at their
5' ends with 32P and digested with snake venom phosphodi-
esterase or exonuclease I, and the products were resolved by
electrophoresis. Both enzymes gave pT as the predominant ter-
minal mononucleotide and pTpC as the terminal dinucleotide.
We conclude that PaeR7 cleaves at the same position as Xho I
within the sequence 5' C I T-C-G-A-G 3'.
Although PaeR7 and Xho I have a common recognition and
cleavage site, there are other properties that distinguish the two
enzymes. PaeR7 and Xho I produce disparate digestion patterns
on an Ad2 DNA substrate (Fig. 4A). This is due to the inability
ofPaeR7 to cleave one of the Xho I sites on the Ad2 genome-
i.e., the site located at nucleotide 9,686 (26.54%) (17). This site
a b c d e f
FIG. 3. A 1.0% agarose gel containingXho I digests of 2 ,ug of 080
DNAs. 480 phages were grown on: E. coli MM294 (lanes a and b),
pPAORM42 (lane c), pPAORM38b (lane d), pPAORM3.8 (lane e),
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FIG. 6. A 1.5% agarose gel containing di-
gests -of pBR322 and pX2281 plasmids (having| 2 a Xho I linker at nucleotide 2,281). Lanes:- a,
pX2281 DNA modified with PaeR7 methylase
and cleaved with Taq I; b, unmodified pX2281
DNA cleaved with Taq I; c, unmodified pBR322
DNA lacking the Xho I linker cleaved with Taq
I. Fragment 1 in pX2281 DNA (lanes a and c)
contained the Xho I linker. When modified with
PaeR7 methylase (lane a), the plasmid was not
cleaved. However, when unmodified (lane b),
pX2281 DNA was cleaved (fragment 2 in lane b,
and another small fragment, not shown, were
generated).
FIG. 4. Separation on a 1.0% agarose gels. (A) Digests of 2 jg of
Ad2 DNA made with crude enzyme extracts and purified enzymes.
Lanes: a, Xho I (purified enzyme); b, extract of PA0303 (pMG7) cells;
c, extract of pPAORM3.8i d, extract of pPAOR1.9; e, PaeR7 (purified,
enzyme). Only lane a shows the presence of the smallest Ad2 fragment
(-a) derived from the cleavage of the site at 26.5%. (B) Digests of 2 mg
of Ad2 DNA. Lanes a, uncut; b, Xho I; c, PaeR7*; d, PaeR7.
was refractory to PaeR7 cleavage regardless ofwhether the DNA
had been isolated from Ad2 virions or as part of an E. coli re-
combinant plasmid, indicating that blockage of cleavage is not
due to DNA modification. Twenty other DNA substrates of
known sequence containing Xho I sites all proved.to be cleav-
able by PaeR7 as well as Xho I.
Experiments were performed with DNA containing the Ad2
26% site to determine what properties were responsible for
blocking cleavage. When. ligated to DNA from a different
source, "hybrid" sites containing sequences from the right side
(toward higher Ad2 map positions) of the 26% site were cleav-
able by both Xho I and PaeR7. However, a hybrid site contain-
ing sequences to the left (toward. lower map positions) of the
original 26% site still was resistant to PaeR7 (Fig. 5).
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ond endonucleolytic activity was observed in PaeR7 prepara-
tions. This activity was found under conditions of low salt, high
glycerol, and high enzyme concentrations with prolonged in-
cubation (Fig. 4B). The second activity was inhibited by high
salt (150 mM NaCI). Under identical digestion conditions, Xho
I showed no secondary activity.
Specificity of the PaeR7 Methylase. We determined which
base is methylated within the PaeR7 recognition site by the
method described' by McClelland (18). Because the central tet-
ranucleotide of the PaeR7 recognition site, T-C-G-A, is also the.
Taq I recognition site (19), all PaeR7 sites are also Taq I sites.
It had been shown previously that Taq I cleavage is blocked by
N6-methyladenine within its recognition site but is insensitive
to the presence of 5-methylcytosine (18, 20). Therefore, failure
of Taq I to cleave a PaeR7 site after it had been modified by the
PaeR7 methylase would indicate that this enzyme is a DNA
adenine methylase. Taq I could not cleave a PaeR7 site (inserted
as a Xho I linker into pBR322) after having been modified by
the PaeR7 methylase (Fig. 6). This result strongly suggests that
the PaeR7 methylase acts at the recognition site to produce 5'
C-T-C-G-mA-G 3'.
9680 9690 9698
...AAAACCT CTCG:AG AAAGGCGi... Ad2
....TTTTGGA GAGCTl TTTCCGC... (26.5%)











FIG. 5. Constructions of hybridPaeR7 sites by using 26.5% site on the Ad2 genome (nucleotides 9,679-9,698). The 26.5% site was leaved with
Xho Iand the two ends (stippled) were religated to otherXho I sites (pX164 is pBR322 plasmidwith aXho I linker at position 164). After the hybrid
sites were constructed, they were digestedwithPaeR7. Sequences 5' to the 26.5% site (towardlower nucleotide numbers)-in Ad2DNA are responsible
for the resistance of this site to cleavage.-
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We have also noted that PaeR7 methylation can block cleav-
age of its recognition site by Xho I and Ava I (C-Py-C-G-Pu-G).
However, this does not necessarily imply that these two en-
zymes have the same cognate methylation site (21).
DISCUSSION
Efforts to clone the genes for various restriction/modification
systems in E. coli have met with success in only four cases:
EcoRI (22), EcoRII (23), Hha II (15), and Pst I (24). It is un-
certain why attempts to clone other systems have not suc-
ceeded. The fact that PaeR7 is a-type II system (25) which is
plasmid-borne (5) facilitated the isolation and transfer of the
genes. Clones containing the PaeR7 system also have been re-
ported by Theriault and Roy (26).
PaeR7 possesses some interesting properties. The inability
of this enzyme to cleave the Ad2 26.5% site is a phenomenon
which, to our knowledge, is unique (27, 28). Although many
restriction endonucleases are known to cleave different sub-
strate sites at variable rates dependent on their flanking se-
quences (3, 27, 28), they eventually do cleave all canonical sites.
In the case of PaeR7, there clearly is an effect induced by the
sequence 5' (toward lower nucleotide numbers) to the Ad2
PaeR7 site which renders the site completely refractory. Com-
puter searches of the sequences up to 150 nucleotides 5' to this
PaeR7 site have not shown the presence of any regions that
could form secondary structures of significant stability. This, of
course, does not preclude the possibility of interactions be-
tween distal regions leading to the formation of a stable struc-
ture. Alterations in the primary flanking sequences will be re-
quired to determine the cause of this inhibition.
The most unusual feature ofthe PaeR7 clones is the finding
that a functioning restriction enzyme gene can be present in the
cell without an accompanying methylase gene. In other restric-
tion/modification systems, such as the EcoRI and Hha II sys-
tems, the presence of the restriction enzyme gene without its
corresponding methylase is lethal (ref. 29; B. Schoner and H.
Smith, personal communication). Consequently, obtaining
clones that are endonuclease' methylase- was unexpected.
Although the mechanism that makes the PaeR7 clones viable
is not yet known, experiments involving the pPAORL.9 clone
demonstrate that the restriction enzyme in this clone is not ac-
tive in vivo because 080 phage can grow unrestricted. There
are at least three possible explanations of this phenomenon.
First, it may be that the restriction enzyme is physically sep-
arated from the cell's DNA. Preliminary experiments attempt-
ing to release periplasmic proteins by subjecting the cells to
osmotic shock failed to release the PaeR7 endonuclease, sug-
gesting that compartmentalization does not involve its location
in the periplasmic space.
A second possibility is that the PaeR7 restriction gene has
undergone mutation and now codes for an altered protein that
is nonfunctional under physiological conditions. There is a pre-
cedent for this-the occurrence of such a mutation in clones
containing the EcoRI system. A spontaneous mutation in the
endonuclease gene (30) resulted in a mutant that was unable to
restrict incoming A phage; nevertheless, extracts of the mutant
cells contained high levels ofendonuclease activity. The mutant
form ofthe enzyme differs-from the wild type in optimal reaction
parameters (P. Greene, personal communication). To deter-
mine whether a similar mutation has occurred in the PaeR7 sys-
tem, it will be necessary to compare the DNA sequences ofthe
restriction gene from pPAORL9 (endonuclease' methylase&)
with the gene from pPAORMS.8 (endonuclease' methylase')
digestion produced clones with inserts of variable length, all of
which were endonuclease' methylase-. Therefore, a mutation
altering the in vivo activity of the PaeR7 endonuclease gene
would have to be common to all of these constructs.
The third possibility is that in the PaeR7 system the presence
of the restriction endonucleasealone is not sufficient for in vivo
activity. Another gene product may be required to elicit the in
vivo activity. The control element, whatever its composition,
may have evolved specifically to aid this plasmid-borne system
during the transfer of the plasmid between different bacteria.
The presence of a third factor would imply that type II restric-
tion/modification systems are a more complex and diverse
group than has been assumed.
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